Stock A299660 CELLID, CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Cellid, Co., Ltd.

Equities

A299660

KR7299660001

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
2,850 KRW +0.88% Intraday chart for Cellid, Co., Ltd. -20.83% -36.24%
2023 Cellid, Co., Ltd.(KOSDAQ:A299660) dropped from S&P Global BMI Index CI
2021 Private S.Korea firms plan $5.4 billion investment to create vaccine hub RE

Company Profile

Cellid, Co., Ltd. is a Korea-based company mainly engaged in the research and development of cancer therapeutic vaccine. The Company develops cancer therapeutic vaccine through development and clinical research of BVAC pipeline products using CeliVax original technology.
Sector
Biotechnology & Medical Research
Calendar
2024-08-08 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CELLID, CO., LTD. Stock Cellid, Co., Ltd.
-36.24% 28.03M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+11.91% 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.60% 106B
BIONTECH SE Stock BioNTech SE
-4.68% 24.28B
ARGENX SE Stock argenx SE
-0.82% 21.96B
GENMAB A/S Stock Genmab A/S
-10.12% 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.12% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.47% 15.56B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.77% 13.63B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.58% 12.27B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A299660 Stock
  4. Funds and ETFs Cellid, Co., Ltd.